These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7969325

  • 1. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria.
    Milliner DS, Eickholt JT, Bergstralh EJ, Wilson DM, Smith LH.
    N Engl J Med; 1994 Dec 08; 331(23):1553-8. PubMed ID: 7969325
    [Abstract] [Full Text] [Related]

  • 2. Vitamin B6 resistant primary hyperoxaluria type I. Report of 5 cases.
    Streefland M, Donckerwolcke RA.
    Helv Paediatr Acta; 1989 Feb 08; 43(4):313-24. PubMed ID: 2708072
    [Abstract] [Full Text] [Related]

  • 3. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria.
    Marangella M, Cosseddu D, Petrarulo M, Vitale C, Linari F.
    Nephrol Dial Transplant; 1993 Feb 08; 8(12):1333-7. PubMed ID: 8159301
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
    Milliner DS, Wilson DM, Smith LH.
    Kidney Int; 2001 Jan 08; 59(1):31-6. PubMed ID: 11135054
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary hyperoxaluria type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort.
    van der Hoeven SM, van Woerden CS, Groothoff JW.
    Nephrol Dial Transplant; 2012 Oct 08; 27(10):3855-62. PubMed ID: 22844106
    [Abstract] [Full Text] [Related]

  • 11. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.
    Morgan SH, Maher ER, Purkiss P, Watts RW, Curtis JR.
    Nephrol Dial Transplant; 1988 Oct 08; 3(1):28-32. PubMed ID: 3132636
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR, Chen D, MacLennan GT, Resnick MI, Jacobs GH.
    J Urol; 2004 Mar 08; 171(3):1304-8. PubMed ID: 14767338
    [Abstract] [Full Text] [Related]

  • 14. Absorptive hyperoxaluria: a new clinical entity--successful treatment with hydrochlorothiazide.
    Yendt ER, Cohanim M.
    Clin Invest Med; 1986 Mar 08; 9(1):44-50. PubMed ID: 3955921
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An inheritable anomaly of red-cell oxalate transport in "primary" calcium nephrolithiasis correctable with diuretics.
    Baggio B, Gambaro G, Marchini F, Cicerello E, Tenconi R, Clementi M, Borsatti A.
    N Engl J Med; 1986 Mar 06; 314(10):599-604. PubMed ID: 3945245
    [Abstract] [Full Text] [Related]

  • 19. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.
    Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G.
    N Engl J Med; 1994 Mar 31; 330(13):877-84. PubMed ID: 8114857
    [Abstract] [Full Text] [Related]

  • 20. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B, von Unruh GE, Blank G, Rietschel E, Sidhu H, Laube N, Hesse A.
    Am J Kidney Dis; 2005 Sep 31; 46(3):440-5. PubMed ID: 16129205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.